Chronic graft-versus-host disease with skin signs suspicious for squamous cell carcinoma

ISSN： 0284-186X

Source： Acta Oncologica, Vol.52, Iss.6, 2013-08, pp. : 1213-1214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Standardizing chronic graft-versus-host disease

By van Besien Koen

Future Oncology, Vol. 2, Iss. 4, 2006-08 ,pp. : 459-462

Future Medicine

Access to resources Recommend Favorite

Transfusion-associated graft-versus-host disease: an update

By Dal-Pont Christian Schennach Harald

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 254-257

Springer Publishing Company

Access to resources Recommend Favorite

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen

By Saillard Colombe Crocchiolo Roberto Furst Sabine El-Cheikh Jean Castagna Luca Signori Alessio Oudin Claire Faucher Catherine Lemarie Claude Chabannon Christian Granata Angela Blaise Didier

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1106-1112

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation

By Sellar Rob S Peggs Karl S

Future Oncology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1549-1565

Future Medicine

Access to resources Recommend Favorite

Tacrolimus (FK506) for Graft-versus-host Disease after Allogeneic Blood Stem Cell Transplantation for Hematologic Malignancies

By Gerull S. Luft T. Scheuer M. Kornacker M. Gebest H. J. Schőnland S. Perz J. Ho A. D.

The Chinese-German Journal of Clinical Oncology, Vol. 3, Iss. 1, 2004-03 ,pp. : 2-4

Springer Publishing Company

Access to resources Recommend Favorite